IP Library Patent Application 17617453
Patent Application
App. No. 17/617,453

Antibacterial Dosage Regime Using Cannabinoids

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
17/617,453
Abstract

The present invention provides methods, compositions and uses for treating topical bacterial infections comprising the administration of cannabinoids. In particular, the present invention provides methods, uses and compositions for treating bacterial infections, the compositions comprising cannabidiol or other cannabinoids, in a dose ranging from about 25 mg to about 500 mg of the cannabinoid compounds.

Claims (15)

1 .- 21 . (canceled)

22 . A method for treating or reducing the risk of a bacterial infection, the method comprising topically administering a composition comprising 25 mg-2000 mg of a cannabinoid to a subject in need thereof

23 . The method of claim 22 , wherein the composition comprises 25 mg-500 mg of a cannabinoid.

24 . The method of claim 22 , wherein the infection is a topical infection and the composition is administered to the skin a mucosal surface.

25 . The method of claim 22 , wherein the composition is administered to the eye.

26 . The method of claim 22 , wherein the infection is an ocular infection and the composition is administered to the eye.

27 . The method of claim 22 , wherein the composition is administered to nasal mucosal tissue.

28 . The method of claim 27 , wherein the composition is inhaled.

29 . The method of claim 22 , wherein the bacterial infection is infection by a gram positive bacteria.

30 . The method of claim 29 , wherein the gram positive bacteria is: Streptococcus spp., Peptostreptococcus spp., Clostridium spp., Listeria spp., Bacillus spp., Staphylococcus spp., Propionibacterium spp., Kocuria spp., and Corynebacterium spp., and combinations thereof

31 . The method of claim 22 , wherein the bacteria is biofilm-forming bacteria.

32 . The method of claim 22 , wherein the bacteria is resistant to at least one antibiotic.

33 . The method of claim 22 , wherein the composition is a ointment or a gel.

34 . The method of claim 22 , wherein the composition comprises one or more poly (substituted or unsubstituted alkylene) glycols or a derivative thereof

35 . The method of claim 22 , wherein the composition is gel and comprises at least one of a siloxane and a low molecular weight alcohol and further comprises a viscosity modifier that increase the viscosity of the composition.

Assignments (2)
SECURITY INTEREST Recorded Jun 9, 2025
From: BOTANIX PHARMACEUTICALS LTD; BOTANIX SB INC.
To: KREOS CAPITAL VII (UK) LIMITED
Reel/Frame 071363/0010 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2022
From: THURN, MICHAEL
To: BOTANIX PHARMACEUTICALS LIMITED
Reel/Frame 058845/0226 →